Jane Street
OCUL icon

Jane Street’s Ocular Therapeutix OCUL Stock Holding History

Jane Street’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481K Sell
49,000
-261,700
-84% -$2.37M ﹤0.01% 8113
2026
Q1 		$2.63M Buy
310,700
+79,200
+34% +$755K ﹤0.01% 4592
2025
Q4 		$2.81M Sell
231,500
-100
-0% -$1.22K ﹤0.01% 4156
2025
Q3 		$2.71M Buy
231,600
+22,500
+11% +$269K ﹤0.01% 4401
2025
Q2 		$1.94M Buy
+209,100
New +$1.64M ﹤0.01% 4463
2025
Q1 		– Sell
-33,100
Closed -$283K – 10269
2024
Q4 		$283K Buy
33,100
+14,000
+73% +$137K ﹤0.01% 7832
2024
Q3 		$166K Buy
+19,100
New +$157K ﹤0.01% 8764
2024
Q1 		– Sell
-12,000
Closed -$53.5K – 9822
2023
Q4 		$53.5K Buy
12,000
+300
+3% +$887 ﹤0.01% 8766
2023
Q3 		$36.7K Sell
11,700
-78,900
-87% -$323K ﹤0.01% 8217
2023
Q2 		$467K Buy
+90,600
New +$539K ﹤0.01% 6420
2022
Q1 		– Sell
-22,600
Closed -$158K – 10818
2021
Q4 		$158K Sell
22,600
-21,000
-48% -$163K ﹤0.01% 8969
2021
Q3 		$436K Sell
43,600
-1,600
-4% -$18K ﹤0.01% 7540
2021
Q2 		$641K Buy
+45,200
New +$687K ﹤0.01% 6772
2021
Q1 		– Sell
-16,600
Closed -$344K – 9445
2020
Q4 		$344K Buy
+16,600
New +$247K ﹤0.01% 6229
2020
Q3 		– Sell
-132,900
Closed -$1.11M – 7680
2020
Q2 		$1.11M Buy
132,900
+113,100
+571% +$750K ﹤0.01% 3915
2020
Q1 		$98K Buy
+19,800
New +$97.8K ﹤0.01% 4942

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's OCUL Position: Q2 2026 in Review

Jane Street sold out of Ocular Therapeutix (OCUL) in Q2 2026, closing a stake of 804,589 shares — an estimated $7.29M sold.

Jane Street first reported a position in OCUL in Q2 2018 and held it in 23 quarters. The position peaked at $12.6M in Q4 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Jane Street reported no remaining Ocular Therapeutix position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 804,589 Ocular Therapeutix shares in Q2 2026, an estimated $7.29M.
  • Jane Street first reported a position in Ocular Therapeutix in Q2 2018 and held it in 23 quarters.
  • Jane Street's Ocular Therapeutix position peaked at $12.6M in Q4 2025.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.